“…The chronic phase of CD is characterised by a wide variety of symptoms ranging from the absence of specific clinical alterations despite positive serology (chronic indeterminate presentation) to the presence of cardiac and/or digestive disturbances (cardiac and digestive presentation respectively). These symptoms, in addition to ageing, poor sociocultural conditions, the stigma of the disease and the urbanisation of recent years may influence the quality of life (QoL) of these individuals .…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the survival of many more patients suffering from chronic diseases, mainly due to improvements in their treatment, has transformed the QoL into a therapeutic target . However, studies examining QoL among patients with Chagas disease and its associated factors are scarce .…”
The low socioeconomic status and the physical limitations imposed by the disease presented an important impact on the QoL reduction among CD patients, especially on environment and physical domains. Strategies to improve QoL among CD patients should be tailored and consider many different variables to maximise improvements not only of patients' physical but also of their mental health.
“…The chronic phase of CD is characterised by a wide variety of symptoms ranging from the absence of specific clinical alterations despite positive serology (chronic indeterminate presentation) to the presence of cardiac and/or digestive disturbances (cardiac and digestive presentation respectively). These symptoms, in addition to ageing, poor sociocultural conditions, the stigma of the disease and the urbanisation of recent years may influence the quality of life (QoL) of these individuals .…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the survival of many more patients suffering from chronic diseases, mainly due to improvements in their treatment, has transformed the QoL into a therapeutic target . However, studies examining QoL among patients with Chagas disease and its associated factors are scarce .…”
The low socioeconomic status and the physical limitations imposed by the disease presented an important impact on the QoL reduction among CD patients, especially on environment and physical domains. Strategies to improve QoL among CD patients should be tailored and consider many different variables to maximise improvements not only of patients' physical but also of their mental health.
Resumo Objetivou-se identificar as manifestações e as estratégias de enfrentamento da doença de Chagas que impactam na qualidade de vida do sujeito acometido. Trata-se de estudo de revisão sistemática de literatura, realizada nas bases de dados PubMed, SciELO e Lilacs, através das quais se reuniu um quantitativo de 6 artigos, além de 6 publicações identificadas por meio de verificação de lista bibliográfica e 4 trabalhos mediante busca manual, os quais foram avaliados por dois revisores de maneira independente. As variáveis tratadas foram enquadradas nos eixos temáticos: manifestações da doença de Chagas que interferem na qualidade de vida do indivíduo e estratégias de enfrentamento que impactam na qualidade de vida de pacientes acometidos por doença de Chagas, subdivididos em três dimensões: domínio físico, domínio psicológico e domínio social. Os resultados visualizados em todos os domínios tratados demonstraram qualidade de vida comprometida pelo acometimento da doença; medidas de enfrentamento limitadas, em sua maioria, à dimensão física do paciente; além de registros incipientes de estudos na área. Sugere-se a exploração da temática proposta, acreditando-se que o conhecimento do convívio do portador com a doença promove a elaboração de estratégias de intervenção em saúde eficazes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.